Current scenario of pyrazole hybrids with in vivo therapeutic potential against cancers

Z Xu, Y Zhuang, Q Chen - European Journal of Medicinal Chemistry, 2023 - Elsevier
Chemotherapeutics occupy a pivotal role in the medication of different types of cancers, but
the prevalence and mortality rates of cancer remain high. The drug resistance and low …

Current status and future prospects of molecular hybrids with thiazolidinedione (TZD) scaffold in anticancer drug discovery

K Tilekar, O Shelke, N Upadhyay, A Lavecchia… - Journal of Molecular …, 2022 - Elsevier
Thiazolidinedione (TZD) containing derivatives have been proved to be promising
anticancer agents in preclinical and clinical evaluation phases. Hybrid molecules not just …

Inclusion of nitrofurantoin into the realm of cancer chemotherapy via biology-oriented synthesis and drug repurposing

PA Elzahhar, HA Nematalla, H Al-Koussa… - Journal of Medicinal …, 2023 - ACS Publications
Structural modifications of the antibacterial drug nitrofurantoin were envisioned, employing
drug repurposing and biology-oriented drug synthesis, to serve as possible anticancer …

Synthesis of tetracyclic spirooxindolepyrrolidine-engrafted hydantoin scaffolds: crystallographic analysis, molecular docking studies and evaluation of their …

A Toumi, FIA Abdella, S Boudriga, TYA Alanazi… - Molecules, 2023 - mdpi.com
In a sustained search for novel potential drug candidates with multispectrum therapeutic
application, a series of novel spirooxindoles was designed and synthesized via …

Double-edged swords: diaryl pyrazoline thiazolidinediones synchronously targeting cancer epigenetics and angiogenesis

N Upadhyay, K Tilekar, S Safuan, AP Kumar… - Bioorganic …, 2021 - Elsevier
In the present study, two novel series of compounds incorporating naphthyl and pyridyl
linker were synthesized and biological assays revealed 5-((6-(2-(5-(2-chlorophenyl)-3-(4 …

Multi-target weapons: diaryl-pyrazoline thiazolidinediones simultaneously targeting VEGFR-2 and HDAC cancer hallmarks

N Upadhyay, K Tilekar, S Safuan, AP Kumar… - RSC Medicinal …, 2021 - pubs.rsc.org
In anticancer drug discovery, multi-targeting compounds have been beneficial due to their
advantages over single-targeting compounds. For instance, VEGFR-2 has a crucial role in …

Rational design, synthesis and biological evaluation of novel pyrazoline-based antiproliferative agents in MCF-7 cancer cells

MM Fakhry, K Mahmoud, MS Nafie, AO Noor… - Pharmaceuticals, 2022 - mdpi.com
Breast cancer is a disease in which cells in the breast divide continuously without control.
There are great limitations in cancer chemotherapy. Hence, it is essential to search for new …

[PDF][PDF] Synthesis and in silico approaches of new symmetric bis-thiazolidine-2, 4-diones as Ras and Raf oncoproteins inhibitors

O Crisan, G Marc, C Nastasă, S Oniga, L Vlase… - …, 2023 - farmaciajournal.com
Millions of people die of cancer every year, all around the world. Unfortunately, the
conventional chemotherapy is associated with some pharmacotoxicological …

Hybrid arginine-modified phospholipid nanotherapeutics based on multitarget quinoxalin-2-ones for cancer-cells delivery

TN Pashirova, LV Mustakimova, IR Nizameev… - Journal of Molecular …, 2024 - Elsevier
The strategy implementing multitarget hybrid molecules as potential chemotherapeutic
agents to overcome resistance and increase efficiency is promising for different forms of …

[HTML][HTML] The effect of the nucleolar protein ZNF385A on the ribosomal DNA copy number variation in response to Cr (VI)-induced DNA damage

H Xu, F Wu, C Ding, Y Qin, W Sun, L Feng… - Ecotoxicology and …, 2024 - Elsevier
Abstract Hexavalent chromium [Cr (VI)] is a widely distributed carcinogen in industrial
contexts and general environmental contexts. Emerging research highlights the central role …